Rating History for Avadel Pharmaceuticals (AVDL) by UBS

More Stocks Rated by UBS | Latest Ratings for AVDL
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/28/2025 Ashwani Verma Downgrade Neutral
(Buy)		 20.00
(N/A)		 18.56
(21.64)		 16.59% Details